Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Invasive candidiasis (IC) is an important healthcare-related infection, with increasing incidence and a crude mortality exceeding 50%. Numerous treatment options are available yet comparative studies have not identified optimal therapy. METHODS: We conducted an individual patient-level quantitative review of randomized trials for treatment of IC and to assess the impact of host-, organism-, and treatment-related factors on mortality and clinical cure. Studies were identified by searching computerized databases and queries of experts in the field for randomized trials comparing the effect of ≥2 antifungals for treatment of IC. Univariate and multivariable analyses were performed to determine factors associated with patient outcomes. RESULTS: Data from 1915 patients were obtained from 7 trials. Overall mortality among patients in the entire data set was 31.4%, and the rate of treatment success was 67.4%. Logistic regression analysis for the aggregate data set identified increasing age (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.00-1.02; P = .02), the Acute Physiology and Chronic Health Evaluation II score (OR, 1.11; 95% CI, 1.08-1.14; P = .0001), use of immunosuppressive therapy (OR, 1.69; 95% CI, 1.18-2.44; P = .001), and infection with Candida tropicalis (OR, 1.64; 95% CI, 1.11-2.39; P = .01) as predictors of mortality. Conversely, removal of a central venous catheter (CVC) (OR, 0.50; 95% CI, .35-.72; P = .0001) and treatment with an echinocandin antifungal (OR, 0.65; 95% CI, .45-.94; P = .02) were associated with decreased mortality. Similar findings were observed for the clinical success end point. CONCLUSIONS: Two treatment-related factors were associated with improved survival and greater clinical success: use of an echinocandin and removal of the CVC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Two RCTs have been published (119, 120); one failed to achieve a difference in time-to-antimicrobials between arms (120) and the other found no significant difference in mortality despite a 90-minute difference in median time interval to antimicrobial administration (119).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Source control of infectious foci was associated with improved survival in recent observational and cluster randomized studies (120,263,264).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Treatment with FLC often fails despite isolates being drug susceptible when tested in vitro, and rates of persistent candidemia are often higher in patients treated with FLC rather than with echinocandins 58 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [58]
In the citing paper
“The most recent Infectious Disease Society of America (IDSA)125 and European guidelines126,127 recommend echinocandins as first-line initial treatment for most invasive candidiasis in both neutropenic and non-neutropenic patients prior to identification to the species level due to their broad spectrum of activity, favorable side effect profile, mortality benefit, and the increasing incidence of az”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [130]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 3×
“mon cause of nosocomial bloodstream infection [1–4].”
BackgroundMermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Biofilms and Device-Associated Infections
Donlan, R. M. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010226 · Cited by 1,504
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Cited by
Items 101–200 of 804
Antifungal Therapy: New and Evolving Therapies
Nivoix, Y., Ledoux, M., & Herbrecht, R. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-3400291 · Cited by 109
Lepak, A. J., Marchillo, K., & Andes, D. R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04445-14 · Cited by 103
Self-citationFan, X., Xiao, M., Zhang, D., Huang, J.-J., Wang, H., Hou, X., Zhang, L., Kong, F., Chen, S. C.-A., Tong, Z.-H., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.007 · Cited by 94
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
Ibrexafungerp: A novel oral glucan synthase inhibitor
Davis, M. R., Donnelley, M. A., & Thompson, G. R. (2020) · Medical Mycology · doi:10.1093/mmy/myz083 · Cited by 91
Whang, D. W., Miller, L. G., Partain, N. M., & McKinnell, J. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-13 · Cited by 91
Thompson, G. R., Soriano, À., Honoré, P. M., Bassetti, M., Cornely, O. A., Kollef, M. H., Kullberg, B. J., Pullman, J. R., Hites, M., Fortün, J., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00551-0 · Cited by 94
Self-citationStrength in numbers: antifungal strategies against fungal biofilms
Ramage, G., Robertson, S. N., & Williams, C. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.023 · Cited by 101
The prevention, diagnosis and management of central venous line infections in children
Chesshyre, E. L. D., Goff, Z., Bowen, A. C., & Carapetis, J. R. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.04.029 · Cited by 97
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
Thompson, G. R., Donnelley, M., & Zhu, E. (2016) · Infection and Drug Resistance · doi:10.2147/idr.s81416 · Cited by 99
El-Baz, A. M., Mosbah, R., Goda, R. M., Mansour, B., Sultana, T., Dahms, T. E. S., & El-Ganiny, A. M. (2021) · Antibiotics · doi:10.3390/antibiotics10010081 · Cited by 93
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
Wasmann, R. E., Muilwijk, E. W., Burger, D. M., Verweij, P. E., Knibbe, C. A. J., & Brüggemann, R. J. M. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0578-5 · Cited by 92
Farmakiotis, D., Kyvernitakis, A., Tarrand, J. J., & Kontoyiannis, D. P. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.006 · Cited by 86
Tadec, L., Talarmin, J., Gastinne, T., Bretonnière, C., Miegeville, M., Pape, P. L., & Morio, F. (2016) · Mycoses · doi:10.1111/myc.12470 · Cited by 88
Azole Resistance in Candida glabrata
Whaley, S. G., & Rogers, P. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0554-5 · Cited by 85
Candidemia in the elderly: What does it change?
Barchiesi, F., Orsetti, E., Mazzanti, S., Trave, F., Salvi, A., Nitti, C., & Manso, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176576 · Cited by 95
Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Borroto-Esoda, K., & Castanheira, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00161-17 · Cited by 84
Ruhnke, M., Cornely, O. A., Schmidt‐Hieber, M., Alakel, N., Boell, B., Buchheidt, D., Christopeit, M., Hasenkamp, J., Heinz, W., Hentrich, M., et al. (2020) · Mycoses · doi:10.1111/myc.13082 · Cited by 88
Wang, E., Farmakiotis, D., Yang, D., McCue, D. A., Kantarjian, H. M., Kontoyiannis, D. P., & Mathisen, M. S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv087 · Cited by 82
T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward
Clancy, C. J., & Nguyen, M. H. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky050 · Cited by 82
Chen, S. C., Sorrell, T. C., Chang, C. C., Paige, E. K., Bryant, P. A., & Slavin, M. A. (2014) · Internal Medicine Journal · doi:10.1111/imj.12597 · Cited by 88
Bailly, S., Maubon, D., Fournier, P., Pelloux, H., Schwebel, C., Chapuis, C., Foroni, L., Cornet, M., & Timsit, J. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.09.041 · Cited by 90
Clinical perspectives on echinocandin resistance among Candida species
Shields, R. K., Nguyen, M. H., & Clancy, C. J. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000215 · Cited by 85
Future directions for anti-biofilm therapeutics targetingCandida
Nett, J. E. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.885838 · Cited by 94
T2Candida for the Diagnosis and Management of Invasive Candida Infections
Monday, L., Acosta, T. J. P., & Alangaden, G. J. (2021) · Journal of Fungi · doi:10.3390/jof7030178 · Cited by 78
Dominguez, E., Zarnowski, R., Sanchez, H., Covelli, A. S., Westler, W. M., Azadi, P., Nett, J., Mitchell, A. P., & Andes, D. R. (2018) · mBio · doi:10.1128/mbio.00451-18 · Cited by 77
Self-citationInvasive Fungal Infections in the Intensive Care Unit
Ostrosky-Zeichner, L., & Al-Obaidi, M. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.005 · Cited by 76
Candida biofilm production is associated with higher mortality in patients with candidaemia
Vitális, E., Nagy, F., Tóth, Z., Forgács, L., Bozó, A., Kardos, G., Majoros, L., & Kovács, R. (2020) · Mycoses · doi:10.1111/myc.13049 · Cited by 74
Candidemia in children: Epidemiology, prevention and management
Mantadakis, E., Pana, Z. D., & Zaoutis, T. E. (2018) · Mycoses · doi:10.1111/myc.12792 · Cited by 77
How Biofilm Growth Affects Candida-Host Interactions
Eix, E. F., & Nett, J. E. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01437 · Cited by 77
Occurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Functions of Sphingolipids in Pathogenesis During Host–Pathogen Interactions
Wang, J., Chen, Y., Li, Y.-K., Chen, D., He, J.-F., & Yao, N. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.701041 · Cited by 73
Management bundles for candidaemia: the impact of compliance on clinical outcomes
Takesue, Y., Ueda, T., Mikamo, H., Oda, S., Takakura, S., Kitagawa, Y., KOHNO, S., on behalf of the ACTIONs Project, Masuda, A., Yoshida, C., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku414 · Cited by 77
Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs
Nett, J. E., & R. Andes, D. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0008-2014 · Cited by 60
Self-citationGhrenassia, E., Mokart, D., Mayaux, J., Demoule, A., Rezine, I., Kerhuel, L., Calvet, L., JONG, A. D., Azoulay, É., & Darmon, M. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0539-2 · Cited by 73
Pfaller, M. A., Carvalhaes, C., Messer, S. A., Rhomberg, P. R., & Castanheira, M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00099-20 · Cited by 68
“analysis of randomized clinical trials comparing treatment for candidemia and invasive candidiasis (IC) 66 showed that initial therapy with an echinocandin was a significant predictor of survival (13).”
Keighley, C., Cooley, L., Morris, A. J., Ritchie, D., Clark, J. E., Boan, P., & Worth, L. J. (2021) · Internal Medicine Journal · doi:10.1111/imj.15589 · Cited by 73
Hirano, R., Sakamoto, Y., Kudo, K., & Ohnishi, M. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s80677 · Cited by 74
Calcineurin Controls Hyphal Growth, Virulence, and Drug Tolerance of Candida tropicalis
Chen, Y., Yu, S.-J., Huang, H., Chang, Y.-L., Lehman, V. N., Silao, F. G. S., Bigol, U. G., Bungay, A. A. C., Averette, A. F., & Heitman, J. (2014) · Eukaryotic Cell · doi:10.1128/ec.00302-13 · Cited by 74
Sphingolipid Biosynthetic Pathway Genes FEN1 and SUR4 Modulate Amphotericin B Resistance
Sharma, S., Alfatah, Bari, V. K., Rawal, Y., Paul, S. K., & Ganesan, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02130-13 · Cited by 77
Ericson, J. E., Kaufman, D. A., Kicklighter, S. D., Bhatia, J., Testoni, D., Gao, J., Smith, P. B., Prather, K. O., & Benjamin, D. K. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw363 · Cited by 68
Haque, F., Verma, N. K., Alfatah, M., Bijlani, S., & Bhattacharyya, M. S. (2019) · RSC Advances · doi:10.1039/c9ra07599b · Cited by 71
Hirayama, T., Miyazaki, T., Ito, Y., Wakayama, M., Shibuya, K., Yamashita, K., Takazono, T., Saijo, T., Shimamura, S., Yamamoto, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60792-y · Cited by 69
Extracellular DNA release confers heterogeneity in Candida albicans biofilm formation
Rajendran, R., Sherry, L., Lappin, D. F., Nile, C. J., Smith, K., Williams, C., Munro, C. A., & Ramage, G. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0303-6 · Cited by 76
Lepak, A. J., Zhao, M., VanScoy, B. D., Ambrose, P. G., & Andes, D. R. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02154-17 · Cited by 67
Self-citationPappas, P. G., Vazquez, J. A., Oren, I., Rahav, G., Aoun, M., Bulpa, P., Ben-Ami, R., Ferrer, R., Mccarty, T., Thompson, G. R., et al. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad256 · Cited by 65
Self-citationGarnacho‐Montero, J., Díaz‐Martín, A., Cantón‐Bulnes, M. L., Ramírez, P., Sierra, R., Arias-Verdú, D., Rodríguez-Delgado, M., Loza-Vázquez, A., Rodriguez-Gomez, J., Gordón, M., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002867 · Cited by 67
Lohse, M. B., Gulati, M., Craik, C. S., Johnson, A. D., & Nobile, C. J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01027 · Cited by 67
Mambro, T. D., Guerriero, I., Aurisicchio, L., Magnani, M., & Marra, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00080 · Cited by 66
Invasive fungal infections in transplant recipients
Vázquez, J. A., Miceli, M. H., & Alangaden, G. J. (2013) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936113491936 · Cited by 69
Factors related to outcome of bloodstream infections due to Candida parapsilosis complex
Barchiesi, F., Orsetti, E., Osimani, P., Catassi, C., Santelli, F., & Manso, E. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1704-y · Cited by 69
Improving the management of candidemia through antimicrobial stewardship interventions
Reed, E. E., West, J. E., Keating, E. A., Pancholi, P., Balada-Llasat, J.-M., Mangino, J. E., Bauer, K. A. A., & Goff, D. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.11.012 · Cited by 66
Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking
Zhao, M., Zhang, F., Zarnowski, R., Barns, K., Jones, R., Fossen, J., Sanchez, H., Rajski, S. R., Audhya, A., Bugni, T. S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145123 · Cited by 62
Self-citationAmphotericin B in the Era of New Antifungals: Where Will It Stand?
Akinosoglou, K., Rigopoulos, E. A., Papageorgiou, D., Schinas, G., Polyzou, E., Dimopoulou, E., Gogos, C. A., & Dimοpoulos, G. (2024) · Journal of Fungi · doi:10.3390/jof10040278 · Cited by 68
Eschenauer, G. A., Nguyen, M. H., Shoham, S., Vazquez, J. A., Morris, A. J., Pasculle, W. A., Kubin, C. J., Klinker, K. P., Carver, P. L., Hanson, K. E., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02163-13 · Cited by 61
Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance
Kotey, F. C. N., Dayie, N. T. K. D., Tetteh‐Quarcoo, P. B., & Donkor, E. S. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211026927 · Cited by 77
Invasive fungal infections in acute and chronic liver impairment: A systematic review
Lahmer, T., Pietrobom, P. M. P., Schmid, R. M., & Colombo, A. L. (2021) · Mycoses · doi:10.1111/myc.13403 · Cited by 61
Liposomal amphotericin B—the present
Maertens, J. A., Pagano, L., Azoulay, É., & Warris, A. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac352 · Cited by 61
Muthamil, S., Devi, V. A., Balasubramaniam, B., Balamurugan, K., & Pandian, S. K. (2018) · Journal of Basic Microbiology · doi:10.1002/jobm.201700529 · Cited by 66
Conserved Inhibition of Neutrophil Extracellular Trap Release by Clinical Candida albicans Biofilms
Kernien, J. F., Johnson, C. J., & Nett, J. E. (2017) · Journal of Fungi · doi:10.3390/jof3030049 · Cited by 63
Lejay, A., Delay, C., Girsowicz, E., Chenesseau, B., Bonnin, E., Ghariani, M., Thaveau, F., Georg, Y., Gény, B., & Chakfé, N. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.07.016 · Cited by 59
Johnson, C. J., Kernien, J. F., Hoyer, A. R., & Nett, J. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-13588-6 · Cited by 58
Synergy of the antibiotic colistin with echinocandin antifungals in Candida species
Zeidler, U., Bougnoux, M.-E., Lupan, A., Helynck, O., Doyen, A., Garcia, Z., Sertour, N., Clavaud, C., Munier-Lehmann, H., Saveanu, C., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks538 · Cited by 58
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 62
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection
Falcone, M., Russo, A., Iraci, F., Carfagna, P., Goldoni, P., Vullo, V., & Venditti, M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01927-15 · Cited by 58
Attributable mortality of candidemia after introduction of echinocandins
Cornely, F. B., Cornely, O. A., Salmanton‐García, J., Koehler, F. C., Koehler, P. A., Seifert, H., Wingen-Heimann, S. M., & Mellinghoff, S. C. (2020) · Mycoses · doi:10.1111/myc.13177 · Cited by 60
Diagnosis and Treatment of Candidemia in the Intensive Care Unit
Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693704 · Cited by 72
Kobayashi, T., Marra, A. R., Schweizer, M. L., Eyck, P. T., Wu, C., Alzunitan, M. A., Salinas, J. L., Siegel, M., Farmakiotis, D., Auwaerter, P. G., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa270 · Cited by 59
Changing epidemiology of candidemia in a medical center in middle Taiwan
Hii, I.-M., Chang, H.-L., Lin, L.-C., Lee, Y.-L., Liu, Y.-M., Liu, C.-E., Chen, C.-H., Cheng, Y.-R., & Chang, C.-Y. (2015) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2013.08.017 · Cited by 56
Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-13 · Cited by 56
Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study
Aguilar, G., Delgado, C., Corrales, I., Izquierdo, A. C., Gracia, E., Moreno, T., Romero, E., Ferrando, C., Carbonell, J., Borrás, R., et al. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1458-4 · Cited by 77
Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All
Kean, R., Delaney, C., Rajendran, R., Sherry, L., Metcalfe, R., Thomas, R., McLean, W., Williams, C., & Ramage, G. (2018) · Journal of Fungi · doi:10.3390/jof4010012 · Cited by 64
Lin, C.-J., & Chen, Y.-L. (2018) · Journal of Fungi · doi:10.3390/jof4020068 · Cited by 55
Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection
Shields, R. K., Nguyen, M. H., Press, E. G., Cumbie, R., Driscoll, E., Pasculle, A. W., & Clancy, C. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01973-15 · Cited by 55
Fernández‐Ruiz, M., Puig‐Asensio, M., Guinea, J., Almirante, B., Padilla, B., Almela, M., Díaz‐Martín, A., Rodríguez‐Baño, J., Cuenca‐Estrella, M., & Aguado, J. M. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.05.009 · Cited by 59
Luzzati, R., Cavinato, S., Giangreco, M., Granà, G., Centonze, S., Deiana, M. L., Biolo, G., & Barbone, F. (2013) · Mycoses · doi:10.1111/myc.12090 · Cited by 61
Wang, H., Liu, N., Yin, M., Han, H., Yue, J., Zhang, F., Shan, T., Guo, H., & Wu, D. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0609-x · Cited by 60
Vaquero-Herrero, M. P., Ragozzino, S., Castaño-Romero, F., Siller, M., González, R. S., García‐Sánchez, J. E., García‐García, M. I., Marcos, M., & la Vega, H. G. T. (2017) · Mycoses · doi:10.1111/myc.12644 · Cited by 55
Diagnostic Performance of T2Candida Among ICU Patients With Risk Factors for Invasive Candidiasis
Arendrup, M. C., Andersen, J. S., Holten, M., Krarup, K. B., Reiter, N., Schierbeck, J., & Helleberg, M. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz136 · Cited by 55
Rahi, M. S., Jindal, V., Pednekar, P., Parekh, J., Gunasekaran, K., Sharma, S., Stender, M., & Jaiyesimi, I. A. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211039050 · Cited by 63
Candida glabrata – unique features and challenges in the clinical management of invasive infections
Glöckner, A., & Cornely, O. A. (2015) · Mycoses · doi:10.1111/myc.12348 · Cited by 58
Hall, R. G., Swancutt, M. A., Meek, C. C., Leff, R. D., & Gumbo, T. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01490-12 · Cited by 57
Chen, P., Chuang, Y., Wang, J., Sheng, W., Yu, C., Chu, C.-C., Hsueh, P., Chang, S., & Chen, Y. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.08.025 · Cited by 54
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey
Kutlu, M., Kutlu, S. S., Çavuş, S. A., Öztürk, Ş. B., Tasbakan, M. I., Özhak, B., Kaya, O., Kutsoylu, O. Ö. E., Akar, Ş. Ş., Turhan, Ö., et al. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04394-0 · Cited by 54
Al‐Hasan, M. N., & Winders, H. R. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.05.012 · Cited by 56
UPC2A Is Required for High-Level Azole Antifungal Resistance in Candida glabrata
Whaley, S. G., Caudle, K. E., Vermitsky, J.-P., Chadwick, S. G., Toner, G., Barker, K. S., Gygax, S. E., & Rogers, P. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02217-13 · Cited by 52
Phongkhun, K., Pothikamjorn, T. L., Srisurapanont, K., Manothummetha, K., Sanguankeo, A., Thongkam, A., Chuleerarux, N., Leksuwankun, S., Meejun, T., Thanakitcharu, J., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad064 · Cited by 75
Rosa, F. G. D., Corcione, S., Filippini, C., Raviolo, S., Fossati, L., Montrucchio, C., Aldieri, C., Petrolo, A., Cavallo, R., & Perri, G. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125149 · Cited by 56
Asadzadeh, M., Ahmad, S., Al‐Sweih, N., & Khan, Z. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0336 · Cited by 53
Ortiz-Roa, C., Valderrama-Ríos, M. C., Sierra-Umaña, S. F., Rodríguez, J. Y., Muñeton-López, G. A., Solórzano, C., Escandón, P., Álvarez, C., & Cortés, J. A. (2023) · Journal of Fungi · doi:10.3390/jof9070715 · Cited by 54
Yang, M., Du, K., Hou, Y., Xie, S., Dong, Y., Li, D., & Du, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02022-18 · Cited by 54
Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection
Levinson, T., Dahan, A., Novikov, A., Paran, Y., Berman, J., & Ben‐Ami, R. (2021) · Mycoses · doi:10.1111/myc.13191 · Cited by 50
Invasive candidiasis: from mycobiome to infection, therapy, and prevention
Lagunes, L., & Rello, J. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2658-0 · Cited by 56
T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications
Zacharioudakis, I. M., Zervou, F. N., & Mylonakis, E. E. (2018) · Journal of Fungi · doi:10.3390/jof4020045 · Cited by 50
Angioinvasive fungal infections impacting the skin
Berger, A. P., Ford, B. A., Brown‐Joel, Z. O., Shields, B. E., Rosenbach, M. A., & Wanat, K. A. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.04.058 · Cited by 50
Cortés, J. A., Ruiz, J. F., Moreno, L. N. M., & Lemos, E. V. (2020) · Biomédica · doi:10.7705/biomedica.4400 · Cited by 61
Breakthrough candidaemia in the era of broad-spectrum antifungal therapies
Cuervo, G., Garcia-Vidal, C., Nucci, M., Puchades, F., Fernández-Ruiz, M., Obed, M., Manzur, A., Gudiol, C., Pemán, J., Aguado, J. M., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.029 · Cited by 49
Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study
Eschenauer, G. A., Carver, P. L., Lin, S., Klinker, K. P., Chen, Y., Potoski, B. A., Shields, R. K., Clancy, C. J., Nguyen, M. H., & Lam, S. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks482 · Cited by 49
Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms
Ho, Y., Liu, F., Yeh, C., Yang, C. M., Lin, C.-C., Lin, T., Hsieh, P., Hu, M., Gong, Z., & Lu, J. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.10.005 · Cited by 49
Metadata
- Authors
- Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group
- Affiliations
- University of Wisconsin–Madison (US)
- University of Alabama at Birmingham (US)
- The University of Queensland (AU)
- Rutgers, The State University of New Jersey (US)
- AstraZeneca (United States) (US)
- Wayne State University (US)
- Radboud University Nijmegen (NL)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-12
- Volume
- 54
- Issue
- 8
- Pages
- 1110-1122
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2134827411
- Cited by
- 793
- References
- 72
- Citations by year
- 2026: 20 · 2025: 46 · 2024: 46 · 2023: 45 · 2022: 42 · 2021: 64 · 2020: 81 · 2019: 46 · 2018: 71 · 2017: 69 · 2016: 58 · 2015: 62 · 2014: 60 · 2013: 54 · 2012: 28
- FWCI
- 45.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive candidiasis, candidemia, antifungal therapy, echinocandins, central venous catheter removal, mortality, clinical cure, risk factors, immunosuppression, Candida tropicalis, APACHE II score
- MeSH terms
- Adult, Aged, Antifungal Agents, Catheterization, Central Venous, Female, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Echinocandins, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.